Quince Pharmaceuticals Private Limited
About Quince Pharmaceuticals Private Limited
Data last updated:
Quince Pharmaceuticals Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the manufacturing segment of the healthcare sector. It was incorporated on 27 July 2006.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U33111DL2006PTC151327.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Suresh Kumar and Zile Singh.
Its last annual general meeting (AGM) was held on 29 September 2008, and its latest financial statements are for the year ended 31 March 2008. The registered office was at 1594 Dda Flats Gtb Enclave, Delhi, India – 110093.
Company details
Contact details
Quince Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered Address1594 Dda Flats Gtb Enclave, Delhi, India – 110093
- IndustryHealthcare, Manufacturing, Medical Appliances and Instruments, Orthopedic Appliances, X-Ray Apparatus, Medical & Surgical Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Quince Pharmaceuticals Private Limited
FY 2008 filings availableFinancial Statement Summary
| Metrics | FY 2007-08 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2007-08 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Quince Pharmaceuticals Private Limited, buy the company report.
Board of directors of Quince Pharmaceuticals Private Limited
Quince Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar | Director | 27 Jul 2006 | 20 Years 3 Months | As last reported |
| Zile Singh | Director | 27 Jul 2006 | 20 Years 3 Months | As last reported |
Legal cases
No court or tribunal cases involving Quince Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Quince Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Quince Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Quince Pharmaceuticals Private Limited has 2 board changes on record since 2006: 2 appointments. The latest: Suresh Kumar was appointed as Director on 27 Jul 2006.
Frequently asked questions
Quince Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Quince Pharmaceuticals was a private limited company based in Delhi, India. The company worked in manufacturing, within the healthcare industry. It was incorporated on 27 July 2006 and is registered under CIN U33111DL2006PTC151327. The company has been struck off by the Registrar of Companies and is no longer operational.
Quince Pharmaceuticals had 2 directors:
- Suresh Kumar - Director
- Zile Singh - Director
The CIN (Corporate Identification Number) of Quince Pharmaceuticals is U33111DL2006PTC151327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Quince Pharmaceuticals is at 1594 Dda Flats Gtb Enclave, Delhi, India – 110093.
Quince Pharmaceuticals was incorporated on 27 July 2006. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Quince Pharmaceuticals on record with the MCA are for the year ended 31 March 2008. Its last annual general meeting was held on 29 September 2008. Year-wise statements from 2015 are in the company report.
Quince Pharmaceuticals operated in the healthcare industry, in the manufacturing segment. It worked in this industry before it was struck off.
Suresh Kumar was appointed as Director on 27 Jul 2006. Zile Singh was appointed as Director on 27 Jul 2006.
Quince Pharmaceuticals can be reached at its registered office: 1594 Dda Flats Gtb Enclave, Delhi, India – 110093.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
